CIM21 Twitter Takeover with @InflammatoryDC

On Friday, June 25, 2021, Kamir J. Hiam-Galvez, PhD, a CRI Postdoctoral Fellow at Stanford University, will take over the Cancer Research Institute Twitter account (@CancerResearch) and share a day in the life of a scientist.  

Dr. Hiam-Galvez, who regularly tweets from @InflammatoryDC, aims to improve our knowledge of the importance of CD4+ “helper” T cells in killing cancer cells using sophisticated new technologies.

Follow CRI Fellow Dr. Hiam-Galvez on Twitter and learn about the single-cell sequencing technology used in a lab. Visit our Twitter account @CancerResearch or follow along with the hashtag #CIM21.

 

Photo by Joshua Hoehne on Unsplash

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son